Brief: Qlife Holding Signed Letter Of Intent With Hipro Biotechnology

Qlife Holding AB

14/09/2023 09:07

Sept 14 (Reuters) - Qlife Holding AB  QLIFE.ST :
    * QLIFE SIGNS LETTER OF INTENT WITH MAJOR INDUSTRY PARTNER
AS PART
OF A B2B STRATEGY TO ENTER MAJOR MARKETS WITH EGOO HEALTH,
THROUGH HOSPITAL-AT-HOME PARTNERSHIPS
    * QLIFE IS PLEASED TO ANNOUNCE THAT IT HAS SIGNED A LETTER
OF
INTENT (LOI) WITH MAJOR INDUSTRY PLAYER, HIPRO BIOTECHNOLOGY, TO
INTRODUCE EGOO HEALTH TO CHINESE MARKET
    * QLIFE ANTICIPATE FINALIZING A COMPREHENSIVE COLLABORATION
AGREEMENT BY END OF THIS YEAR

Source text for Eikon:  ID:nWkrbW882t 
Further company coverage:  QLIFE.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;  +48 58 769 66 00;))